Principal Financial Group Inc. Has $22.77 Million Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Principal Financial Group Inc. lifted its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 3.2% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 264,817 shares of the company's stock after buying an additional 8,291 shares during the period. Principal Financial Group Inc. owned about 0.53% of Prestige Consumer Healthcare worth $22,766,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Franklin Resources Inc. boosted its position in Prestige Consumer Healthcare by 0.7% during the fourth quarter. Franklin Resources Inc. now owns 21,735 shares of the company's stock worth $1,697,000 after acquiring an additional 150 shares during the last quarter. KBC Group NV grew its holdings in Prestige Consumer Healthcare by 7.4% during the 1st quarter. KBC Group NV now owns 2,199 shares of the company's stock worth $189,000 after acquiring an additional 151 shares in the last quarter. CIBC Private Wealth Group LLC grew its holdings in Prestige Consumer Healthcare by 48.9% during the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock worth $34,000 after acquiring an additional 152 shares in the last quarter. McIlrath & Eck LLC boosted its holdings in shares of Prestige Consumer Healthcare by 19.1% in the 4th quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock valued at $75,000 after buying an additional 154 shares in the last quarter. Finally, O Shaughnessy Asset Management LLC boosted its stake in Prestige Consumer Healthcare by 3.0% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 7,026 shares of the company's stock worth $549,000 after purchasing an additional 207 shares during the period. 99.95% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

PBH has been the subject of a number of research analyst reports. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Wall Street Zen upgraded Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $93.33.

Prestige Consumer Healthcare Trading Down 1.6%

Prestige Consumer Healthcare stock traded down $1.21 during trading hours on Friday, reaching $76.33. 507,395 shares of the company's stock traded hands, compared to its average volume of 311,351. The firm has a market capitalization of $3.77 billion, a price-to-earnings ratio of 17.79, a PEG ratio of 2.33 and a beta of 0.43. The firm's 50 day moving average is $83.76 and its 200-day moving average is $82.36. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.82 and a current ratio of 4.20. Prestige Consumer Healthcare Inc. has a fifty-two week low of $64.94 and a fifty-two week high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.30 by $0.02. Prestige Consumer Healthcare had a return on equity of 12.87% and a net margin of 18.86%. The company had revenue of $296.52 million during the quarter, compared to the consensus estimate of $289.36 million. During the same quarter in the prior year, the firm posted $1.02 EPS. The firm's revenue for the quarter was up 7.0% compared to the same quarter last year. On average, analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.